Transcriptomic and bioinformatic analyses further revealed that AGBL4-realted DEGs were enriched in cancer-associated microRNA-related pathways and IL-17 signaling pathway, the latter being notably related to malignancy in central nervous system tumors. Here, AGBL4 is linked to central nervous system cancer.